- Home
- Industry Reports
- Biotechnology
- Healthcare
- Asia-Pacific Biobank Equipment Market – Size, Outlook, Trends and Forecast (2024 – 2032)
The biobank is a type of biorepository which stores the biological samples, usual humans for research in genetics and microbiology. Biobanking equipment is used to conduct various tests, analysis, researches and for the storage of the samples. In many types of research, biological samples are used to manufacture personalised medicine and to study different types of diseases.
Asia Pacific Biobank Market Segments Size & Growth:
Asia Pacific Biobank Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market are increasing demand for precision medicine, research for clinical trials, and advancement in biobanking techniques. However, surveillance issues, storage problem, and the high cost of procedures hinder the growth of the Asia Pacific biobank market.
Asia Pacific Biobank Market Segments Share:
Asia Pacific Biobank Market is categorised into by type which consists of equipment such as incubators, temperature control system, monitoring systems, freezers, and refrigerators. The monitoring systems have the most significant share as they can record the issues in the biobank and intimate immediately.
By Geography, China is dominating the biobank equipment market, and the growth in the Asia Pacific is mainly attributed because of the increasing adoption of personalised medicine and research activities. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, diseases and investment in R&D research.
Asia Pacific Biobank Market Segments Trends:
- In January 2018, Bio-Techne Corporation has acquired Atlanta Biologicals, Inc. stocks to expand regenerative medicine capabilities and cell culture.
- In January 2017, Tecan has brought a new handling biological fluids arm Air LiHa which helps in collecting complex liquids in biobanks and clinical trials.
- In April 2017, Micronics tubes are used to store gynaecological samples by Clinical Cytology biobank at Karolinska Institute to provide high integrity storage and traceable equipment.
- In May 2017, Thermo Fisher Scientific Inc. has been acquired with Patheon a Contract Development and Manufacturing Company.
Asia Pacific Biobank Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Stemcell Technologies Inc.
- BioCision
- Cell & Tissue Systems LLC
- Atlanta Biological
- Biolife Solutions
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in precision medicine
4.1.2 Research and development for clinical trials
4.1.3 Advancement in Biobanks Marketing techniques
4.2 Restraints
4.2.1 Surveillance issues
4.2.2 Problems in storage
4.2.3 Expensive procedures
4.3 Opportunities
4.3.1. Research and understanding on various diseases
4.4 Challenges
4.4.1. Informatics
Chapter 5 Asia Pacific Biobank Equipment Market – By Type
5.1 By Equipment
5.1.1 Incubators
5.1.2 Temperature control systems
5.1.3 Monitoring systems
5.1.4 Freezers
5.1.5 Refrigerators
Chapter 6 Asia Pacific Biobank Equipment Market – By Country
6.1 Introduction
6.2 Asia Pacific
6.2.1. China
6.2.2. India
6.2.3. Japan
6.2.3. South Korea
6.2.5. Australia & New Zealand
6.2.6. Rest of APAC
Chapter 7 Asia Pacific Biobank Equipment Market – Company Profiles
7.1 Cryo BioSystems
7.2 DNA Genotek Inc.
7.3 Beckman Coulter
7.4 Teva Pharmaceutical Industries Ltd
7.5 Tissue Solutions
7.6 Stemcell Technologies Inc.
7.7 BioCision
7.8 Cell & Tissue Systems LLC
7.9 Atlanta Biological
7.10 Biolife Solutions
7.11 Lifeline Scientific Inc.
7.12 Bioniche Pharma USA LLC
7.13 Genzyme Corporation
7.14 Qiagen N.V.
7.15 Biopreservation Media Manufacturers
Chapter 8 Asia Pacific Biobank Equipment Market – Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,030.46 - €6,768.19
- INR: ₹180,726.90 - ₹602,423.01
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,734.01 - £5,780.03
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
The biobank is a type of biorepository which stores the biological samples, usual humans for research in genetics and microbiology. Biobanking equipment is used to conduct various tests, analysis, researches and for the storage of the samples. In many types of research, biological samples are used to manufacture personalised medicine and to study different types of diseases.
Asia Pacific Biobank Market Segments Size & Growth:
Asia Pacific Biobank Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market are increasing demand for precision medicine, research for clinical trials, and advancement in biobanking techniques. However, surveillance issues, storage problem, and the high cost of procedures hinder the growth of the Asia Pacific biobank market.
Asia Pacific Biobank Market Segments Share:
Asia Pacific Biobank Market is categorised into by type which consists of equipment such as incubators, temperature control system, monitoring systems, freezers, and refrigerators. The monitoring systems have the most significant share as they can record the issues in the biobank and intimate immediately.
By Geography, China is dominating the biobank equipment market, and the growth in the Asia Pacific is mainly attributed because of the increasing adoption of personalised medicine and research activities. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, diseases and investment in R&D research.
Asia Pacific Biobank Market Segments Trends:
- In January 2018, Bio-Techne Corporation has acquired Atlanta Biologicals, Inc. stocks to expand regenerative medicine capabilities and cell culture.
- In January 2017, Tecan has brought a new handling biological fluids arm Air LiHa which helps in collecting complex liquids in biobanks and clinical trials.
- In April 2017, Micronics tubes are used to store gynaecological samples by Clinical Cytology biobank at Karolinska Institute to provide high integrity storage and traceable equipment.
- In May 2017, Thermo Fisher Scientific Inc. has been acquired with Patheon a Contract Development and Manufacturing Company.
Asia Pacific Biobank Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Stemcell Technologies Inc.
- BioCision
- Cell & Tissue Systems LLC
- Atlanta Biological
- Biolife Solutions
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in precision medicine
4.1.2 Research and development for clinical trials
4.1.3 Advancement in Biobanks Marketing techniques
4.2 Restraints
4.2.1 Surveillance issues
4.2.2 Problems in storage
4.2.3 Expensive procedures
4.3 Opportunities
4.3.1. Research and understanding on various diseases
4.4 Challenges
4.4.1. Informatics
Chapter 5 Asia Pacific Biobank Equipment Market – By Type
5.1 By Equipment
5.1.1 Incubators
5.1.2 Temperature control systems
5.1.3 Monitoring systems
5.1.4 Freezers
5.1.5 Refrigerators
Chapter 6 Asia Pacific Biobank Equipment Market – By Country
6.1 Introduction
6.2 Asia Pacific
6.2.1. China
6.2.2. India
6.2.3. Japan
6.2.3. South Korea
6.2.5. Australia & New Zealand
6.2.6. Rest of APAC
Chapter 7 Asia Pacific Biobank Equipment Market – Company Profiles
7.1 Cryo BioSystems
7.2 DNA Genotek Inc.
7.3 Beckman Coulter
7.4 Teva Pharmaceutical Industries Ltd
7.5 Tissue Solutions
7.6 Stemcell Technologies Inc.
7.7 BioCision
7.8 Cell & Tissue Systems LLC
7.9 Atlanta Biological
7.10 Biolife Solutions
7.11 Lifeline Scientific Inc.
7.12 Bioniche Pharma USA LLC
7.13 Genzyme Corporation
7.14 Qiagen N.V.
7.15 Biopreservation Media Manufacturers
Chapter 8 Asia Pacific Biobank Equipment Market – Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.